Free Trial

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley logo
$115.07 +2.76 (+2.46%)
As of 02:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
12
Buy
5

Based on 17 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 12 have given a hold rating, and 5 have given a buy rating for MS.

Consensus Price Target

$130.50
13.41% Upside
According to the 17 analysts' twelve-month price targets for Morgan Stanley, the average price target is $130.50. The highest price target for MS is $156.00, while the lowest price target for MS is $105.00. The average price target represents a forecasted upside of 13.41% from the current price of $115.07.
Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

Sign Up

MS Analyst Ratings Over Time

TypeCurrent Forecast
4/24/24 to 4/24/25
1 Month Ago
3/25/24 to 3/25/25
3 Months Ago
1/25/24 to 1/24/25
1 Year Ago
4/25/23 to 4/24/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
8 Buy rating(s)
Hold
12 Hold rating(s)
12 Hold rating(s)
11 Hold rating(s)
11 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$130.50$132.33$131.27$98.07
Forecasted Upside13.41% Upside5.66% Upside-4.78% Downside4.48% Upside
Consensus Rating
Hold
Hold
Hold
Hold

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Morgan Stanley Stock vs. The Competition

TypeMorgan StanleyFinance CompaniesS&P 500
Consensus Rating Score
2.29
2.53
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside13.49% Upside32.01% Upside22.20% Upside
News Sentiment Rating
Positive News

See Recent MS News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/14/2025JPMorgan Chase & Co.
2 of 5 stars
Kian Abouhossein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$125.00 ➝ $122.00+11.89%
4/14/2025Wells Fargo & Company
3 of 5 stars
M. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$130.00 ➝ $120.00+8.00%
4/14/2025JMP Securities
2 of 5 stars
Devin Ryan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
4/2/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Carrier
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$150.00 ➝ $144.00+24.33%
4/1/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Glenn Schorr
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$150.00 ➝ $138.00+20.38%
3/24/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Keith Horowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$135.00 ➝ $125.00+0.67%
3/19/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Richard Ramsden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$144.00 ➝ $126.00+6.24%
3/17/2025Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
H. Engel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
1/21/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brennan Hawken
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$130.00 ➝ $140.00+2.81%
1/17/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jason Goldberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$155.00 ➝ $156.00+13.27%
1/17/2025Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Konrad
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Perform ➝ Market Perform$138.00 ➝ $145.00+6.78%
11/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Martinez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
11/26/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$128.00 ➝ $131.00-2.00%
10/17/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$108.00 ➝ $122.00+1.66%
10/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$120.00 ➝ $135.00+12.69%
7/18/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$116.00 ➝ $118.00+10.42%
7/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
4/16/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$97.00 ➝ $108.00+20.82%
11/28/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$80.00+2.63%
11/20/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$85.00+5.88%
10/23/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$79.15+8.72%
10/20/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
8/1/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$85.00 ➝ $90.00-1.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:34 PM ET.


Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, April 20, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Morgan Stanley:

  • The current stock price is around $109, which may present a buying opportunity for investors looking for value in the financial sector.
  • The company reported strong quarterly earnings, with earnings per share (EPS) of $2.60, exceeding analysts' expectations, indicating robust financial health.
  • Revenue for the latest quarter was $17.74 billion, reflecting a year-over-year increase of 17.2%, showcasing growth potential.
  • Morgan Stanley has a solid dividend yield of 3.39%, providing a steady income stream for investors through its quarterly dividend payments.
  • The firm has a market capitalization of approximately $175.89 billion, indicating its significant presence and stability in the financial services industry.

Morgan Stanley
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Morgan Stanley for these reasons:

  • The stock has experienced fluctuations, with a 52-week high of $142.03 and a low of $90.55, indicating potential volatility.
  • Recent analyst ratings have shown a mix of opinions, with some firms downgrading their ratings, which may signal uncertainty about future performance.
  • The company has a relatively high debt-to-equity ratio of 3.14, suggesting that it relies heavily on debt financing, which can be risky in economic downturns.
  • Insider selling activity has been noted, with significant shares sold recently, which could raise concerns about the confidence of executives in the company's future.
  • The current quick and current ratios are both at 0.80, indicating potential liquidity issues, as these ratios measure the company's ability to meet short-term obligations.

MS Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $130.50, with a high forecast of $156.00 and a low forecast of $105.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last year. There are currently 12 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MS, but not buy additional shares or sell existing shares.

According to analysts, Morgan Stanley's stock has a predicted upside of 13.41% based on their 12-month stock forecasts.

Over the previous 90 days, Morgan Stanley's stock had 1 downgrade by analysts.

Morgan Stanley has been rated by research analysts at Bank of America, Citigroup, Erste Group Bank, Evercore ISI, JMP Securities, JPMorgan Chase & Co., The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.

Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Morgan Stanley less than other "finance" companies. The consensus rating for Morgan Stanley is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how MS compares to other companies.


This page (NYSE:MS) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners